Volta AF-Xplorer II

by Volta Medical  · Based in France → — Advancing the use of AI to transform the treatment of complex cardiac arrhythmias.
Cardiology

Contact for pricing
Regulatory Status Disclosed

Overview

Volta Medical is a health technology company dedicated to revolutionizing the care for complex atrial fibrillation (AF) and atrial tachycardia (AT) patients through breakthrough artificial intelligence (AI) solutions. Founded in 2016 by a data scientist and three electrophysiologists in Marseille, France, Volta Medical’s mission is to improve patient outcomes by developing cutting-edge, data-driven solutions trained on vast procedural datasets.

The Volta AF-Xplorer™ II is the company’s flagship product, a next-generation digital AI companion designed to assist electrophysiologists. It provides real-time identification of spatio-temporal dispersed electrograms (EGMs) during AF and atrial tachycardia procedures. This AI companion technology aims to simplify the real-time assessment of complex AF, offering high stability analysis to provide physicians with an objective method for identifying regions of interest.

Engineered for versatility, AF-Xplorer II integrates seamlessly with leading AF mapping and recording systems and is compatible with most common ablation modalities, including expanded catheter compatibility with devices like the Medtronic Sphere-9™ mapping and ablation catheter. It also offers integration with systems such as the GE HealthCare CardioLab™ AltiX AI.i recording system for a streamlined workflow.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI Companion Technology for complex AF and AT assessment
  • Real-time identification of spatio-temporal dispersed electrograms (EGMs)
  • High stability analysis for objective identification of regions of interest
  • Expanded catheter compatibility, including Medtronic Sphere-9u2122 mapping and ablation catheter
  • Integration with GE HealthCare CardioLabu2122 AltiX AI.i recording system
  • Powered by machine and deep learning algorithms trained on diversified EGM database
  • Analysis of spatio-temporal dispersed EGMs based on dispersion time and intensity stability
  • Booster Mode for increased software sensitivity during AT or slow AF
  • Automated tagging of regions of interest (with compatible mapping systems like EnSite Xu2021)

Use Cases

  • Assisting electrophysiologists during catheter-ablation procedures for complex arrhythmias
  • Real-time assessment of complex Atrial Fibrillation (AF) and Atrial Tachycardia (AT)
  • Identifying areas of interest potentially involved in arrhythmia mechanisms
  • Streamlining procedures and enhancing efficiency in the EP lab

What Physicians Need to Know

ECG/EKG Analysis Capability
Volta AF-Xplorer II analyzes spatio-temporal dispersed electrograms (EGMs) and intra-cardiac atrial electrograms in real-time, providing an objective method for identifying regions of interest during AF and atrial tachycardia procedures. It also offers cycle length estimation from electrograms recorded with mapping and coronary sinus catheters.
Arrhythmia Detection Accuracy
The system is a next-generation AI solution designed for real-time identification of spatio-temporal dispersed EGMs, indicative of arrhythmia drivers, during complex AF and atrial tachycardia ablation procedures. Powered by machine and deep learning algorithms trained on a diversified database of EGMs, it demonstrated superior efficacy in clinical trials. The TAILORED-AF trial showed 88% freedom from AF at 12 months with AI-guided ablation, compared to 70% with PVI-only. The RESTART trial reported 83% freedom from AF and 70% freedom from any atrial arrhythmia at 12 months after one procedure, significantly higher than historical empirical strategies.
Cardiac Monitoring Integration
Volta AF-Xplorer II integrates seamlessly with leading AF mapping and recording systems and is compatible with common ablation modalities, including PFA catheters. Key integrations include the GE HealthCare CardioLabu2122 AltiX AI.i recording system for a unified workspace and enhanced digital communication, and compatibility with the Medtronic Sphere-9u2122 mapping and ablation catheter. It supports both manual and automatic annotation of 3D anatomical and electrical maps.
AHA/ACC Guideline Alignment
Volta Medical's AI solution operates within the context of established cardiac guidelines, referencing the American Heart Association (AHA) definition of atrial fibrillation. Its spatio-temporal dispersion-guided AI solution is also included in a consensus statement from leading international cardiac electrophysiology societies on atrial fibrillation ablation.
Real-Time Alert Capability
The system functions as an AI companion designed to assist electrophysiologists with the real-time identification and annotation of spatio-temporal dispersed electrograms (EGMs) during AF and atrial tachycardia procedures. It cues operators in real-time to regions of interest and provides high stability analysis for objective identification.
Physician Tip

Volta AF-Xplorer II offers electrophysiologists a powerful AI-driven tool for real-time identification of arrhythmia drivers in complex atrial fibrillation and atrial tachycardia, potentially improving ablation outcomes and procedural efficiency. Its advanced dispersion analysis, including high stability analysis, provides objective data to guide ablation strategies. Physicians should leverage its seamless integration with existing mapping and recording systems to optimize workflow and consider its use particularly in persistent AF and redo cases where traditional approaches have limited success. The 'Booster Mode' can be valuable during slow AF or AT to enhance sensitivity.

Volta AF-Xplorer II is engineered for versatility, integrating seamlessly with leading AF mapping and recording systems and compatible with most common ablation modalities, including PFA catheters. Key integrations include the GE HealthCare CardioLabu2122 AltiX AI.i recording system for a unified workspace and enhanced digital communication, and compatibility with the Medtronic Sphere-9u2122 mapping and ablation catheter. It supports bidirectional digital communication with specific 3D mapping systems (e.g., EnSite X) for automatic tagging, simplifying EP lab workflow and reducing hardware footprint.

Details

Category Cardiology AI, Surgical AI
Pricing Contact for pricing
DeploymentIntegrated with existing EP lab systems (mapping and recording systems)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The Volta AF-Xplorer™ II system is a Class IIa Medical Device that is U.S. FDA 510(k) cleared (K251518) and European CE Marked.

Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

Volta AF-Xplorer II is an AI-powered solution designed to assist electrophysiologists in real-time assessment and treatment of complex atrial fibrillation (AF) and atrial tachycardia (AT) during ablation procedures. It utilizes machine and deep learning algorithms trained on a large database of electrograms (EGMs) to identify spatio-temporal dispersed EGMs, which are indicative of arrhythmia drivers. The system aims to standardize EGM interpretation, streamline workflows, and potentially improve long-term outcomes for patients, especially those with persistent and long-standing AF.

Overall: Positive

Strengths

  • Real-time identification of dispersed electrograms (EGMs) and arrhythmia drivers.
  • Improved signal quality and clarity, even in noisy lab environments.
  • Streamlined workflow and simplified mapping process due to side-by-side display and integration with existing systems.
  • Enhanced dispersion stability analysis for objective identification of regions of interest.
  • Expanded compatibility with major EP recording systems, 3D navigation systems, and various mapping and ablation catheters, including PFA catheters.
  • Demonstrated superior efficacy in clinical trials for persistent and long-standing AF compared to conventional ablation methods.

Limitations

  • Procedure and ablation times can be longer compared to PVI-only methods.
  • Relatively new technology, so long-term data beyond current studies is still accumulating.
  • Requires integration with existing EP lab equipment, which might involve initial setup and compatibility considerations.
  • While aiming to standardize, physician interpretation of raw electrograms remains important.
  • No specific contraindications mentioned, but general risks associated with cardiac ablation procedures apply.

Based on reviews from: Volta Medical Official Website, HMP Global Learning Network (EP Lab Digest), Cardiac Rhythm News, PR Newswire, accessdata.fda.gov, BioWorld, TipRanks.com, Elion, AI in Medicine Journal Club, BioSpace, AIS Health, Fierce Biotech, Medical Device and Diagnostic industry

Last updated: 2026-07-19

Ratings & Reviews

Rate Volta AF-Xplorer II

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Volta Medical
Volta Medical Brings Volta AF-Xploreru2122 II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
Volta Medical announced the U.S. launch of its next-generation AI solution, AF-Xplorer II, designed to simplify real-time assessment of complex atrial fibrillation (AF) and assist electrophysiologists during ablation procedures. The system features high stability analysis, expanded catheter compatibility, and integration with GE HealthCare CardioLabu2122 AltiX AI.i recording system.
2025-11
Cardiac Rhythm News
Volta announces US launch of AI-powered AF-Xplorer II system for complex atrial fibrillation - Cardiac Rhythm News
Volta Medical launched its AF-Xplorer II system in the U.S., an AI solution for complex atrial fibrillation, building on its predecessor's success with advancements like high stability analysis, expanded catheter compatibility, and integration with GE HealthCare CardioLab AltiX AI.i. The system had previously received CE Mark approval in Europe.
2025-11
BioSpace
Volta Medical's RESTART Trial Shows Promising Findings for AI Solutions in Recurrent Atrial Fibrillation - BioSpace
Volta Medical announced positive results from the RESTART trial, published in Heart Rhythm, demonstrating improved outcomes for patients with recurrent AF and isolated pulmonary veins who underwent ablation using Volta's AI solution for spatio-temporal dispersion mapping. The AF-Xplorer II is both U.S. FDA 510(k) cleared and European CE Marked.
2026-02
Precedence Research
Volta & GE HealthCare Launch AI for Electrophysiology - Precedence Research
GE HealthCare and Volta Medical launched an integrated software ecosystem, combining the upgraded AF-Xplorer II AI with the GE HealthCare CardioLab AltiX AI.i EP recording platform. This collaboration aims to enhance signal interpretation and data accuracy for complex atrial fibrillation ablation procedures.
2025-11
AIS Health
Volta Files For US FDA Approval Of Next-Gen Cardio Mapping Software After Winning Labeling Expansion - AIS Health
Volta Medical received an FDA labeling expansion for its AF-Xplorer mapping software and has filed for FDA clearance of its second-generation AF-Xplorer II software, which features improved algorithms and deeper data training. The company anticipates clearance by year-end.
2025-06
American Heart Association Journals
Efficiency of Artificial Intelligence-Assisted Temporal Dispersion Mapping with Pulsed Field Ablation: Integration of Volta AF-Xplorer and Affera Sphere-9 System - American Heart Association Journals
A prospective, single-center study evaluated the safety, efficacy, and efficiency of integrating Volta AF-Xplorer with the Affera Sphere-9 mapping system during Pulsed Field Ablation (PFA) for atrial fibrillation. The findings suggest this combined approach is safe, effective, and efficient, showing promise for improving ablation outcomes.
2025-11
Volta Medical
Volta Medical Announces Activities at Heart Rhythm Society 2026 in Chicago, IL, USA.
Volta Medical announced its participation and activities at the Heart Rhythm Society 2026 meeting, indicating ongoing engagement within the electrophysiology community and likely further discussions or presentations related to their AI solutions like AF-Xplorer II.
2026-04
ClinicalTrials.gov (via Research.Patient.info)
VOLta Medical AI-software in REal-World During AF Ablation
This study aims to evaluate the safety and effectiveness of the Volta AF-Xplorer II AI software during catheter ablation for atrial fibrillation in real-world practice over two years. It focuses on patients undergoing ablation for paroxysmal or persistent AF or atrial tachycardia.
unknown

Videos

Product demos, reviews, and walkthroughs for Volta AF-Xplorer II.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

4DMedical (Imbio)
4DMedical
Cardiology AI
4DMedical, with its acquisition of Imbio, offers a comprehensive suite of AI-driven medical imaging solutions for chronic lung and cardiothoracic diseases, providing quantitative and personalized insights from X-ray and CT scans.
Fetal EchoScan (v1.2)
BrightHeart (via AI Agent)
Cardiology AI
Fetal EchoScan (v1.2) is an AI-powered, FDA-cleared software designed to assist physicians in interpreting fetal heart ultrasound examinations for potential congenital heart defects.
Assert-IQ (DM5100)
Abbott (Assert-IQ ICM) / AI Agent (General AI Agent concept)
Cardiology AI
The Assert-IQ™ Insertable Cardiac Monitor (ICM) is a Bluetooth-enabled device from Abbott that provides continuous, real-time heart monitoring and arrhythmia detection, utilizing AI algorithms to reduce false positives and offer long-term diagnostic evaluation for patients with cardiac conditions.
QardioMD
Qardio
Cardiology AI
QardioMD offers an end-to-end virtual care platform with clinical-grade smart devices for remote patient monitoring of various chronic conditions, including hypertension and cardiovascular disease, and integrates with EHR systems.
PrepMD OMNI
PrepMD
Cardiology AI
PrepMD OMNI is an educational platform for cardiac rhythm management technology teams, focusing on training clinicians, hospitals, and practices in CRM device management.
Rapid Enterprise Platform
RapidAI
Cardiology AI
RapidAI's Enterprise Platform offers FDA-cleared, deep clinical AI solutions that connect imaging to clinical action across the health system, integrating with EHRs and PACS for enhanced decision-making and workflow efficiency.

See all Cardiology AI tools →

More from Volta Medical

Volta AF-Xplorer
Volta Medical
Cardiology AI
Volta AF-Xplorer is an AI-assisted mapping and decision-support system for electrophysiology ablation procedures, automatically detecting dispersed electrograms in real-time to guide treatment for complex atrial fibrillation and atrial tachycardia.
VX1
Volta Medical
Cardiology AI
Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
VX1+
Volta Medical
Cardiology AI
AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.